US 11407789
Cell-penetrating compstatin analogs and uses thereof
granted A61KA61K38/00A61K47/645
Quick answer
US patent 11407789 (Cell-penetrating compstatin analogs and uses thereof) held by Apellis Pharmaceuticals, Inc. expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K38/00, A61K47/645